Skip to main content

SUPIROCIN (Freyr Australia Pty Ltd)

Product name
SUPIROCIN
Date registered
Evaluation commenced
Decision date
Approval time
124 (255 working days
Active ingredients
mupirocin calcium
Registration type
New generic medicine
Indication

SUPIROCIN (mupirocin) cream is indicated for the topical treatment of secondarily infected traumatic skin lesions such as small lacerations, sutured wounds or abrasions.

Help us improve the Therapeutic Goods Administration site